Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP481611.RAxSvQKyMUcvGxbVt93DV1H5YOT_cwUCQRHq6prAh3O5g130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP481611.RAxSvQKyMUcvGxbVt93DV1H5YOT_cwUCQRHq6prAh3O5g130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP481611.RAxSvQKyMUcvGxbVt93DV1H5YOT_cwUCQRHq6prAh3O5g130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP481611.RAxSvQKyMUcvGxbVt93DV1H5YOT_cwUCQRHq6prAh3O5g130_provenance.
- NP481611.RAxSvQKyMUcvGxbVt93DV1H5YOT_cwUCQRHq6prAh3O5g130_assertion description "[RNA interference targeting at p65 increased the sensitivity of the ESCC cell lines to 5-fluorouracil, suggesting that NF-kappaB might be a good target for cancer treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP481611.RAxSvQKyMUcvGxbVt93DV1H5YOT_cwUCQRHq6prAh3O5g130_provenance.
- NP481611.RAxSvQKyMUcvGxbVt93DV1H5YOT_cwUCQRHq6prAh3O5g130_assertion evidence source_evidence_literature NP481611.RAxSvQKyMUcvGxbVt93DV1H5YOT_cwUCQRHq6prAh3O5g130_provenance.
- NP481611.RAxSvQKyMUcvGxbVt93DV1H5YOT_cwUCQRHq6prAh3O5g130_assertion SIO_000772 16680372 NP481611.RAxSvQKyMUcvGxbVt93DV1H5YOT_cwUCQRHq6prAh3O5g130_provenance.
- NP481611.RAxSvQKyMUcvGxbVt93DV1H5YOT_cwUCQRHq6prAh3O5g130_assertion wasDerivedFrom befree-20140225 NP481611.RAxSvQKyMUcvGxbVt93DV1H5YOT_cwUCQRHq6prAh3O5g130_provenance.
- NP481611.RAxSvQKyMUcvGxbVt93DV1H5YOT_cwUCQRHq6prAh3O5g130_assertion wasGeneratedBy ECO_0000203 NP481611.RAxSvQKyMUcvGxbVt93DV1H5YOT_cwUCQRHq6prAh3O5g130_provenance.
- befree-20140225 importedOn "2014-02-25" NP481611.RAxSvQKyMUcvGxbVt93DV1H5YOT_cwUCQRHq6prAh3O5g130_provenance.